S100A9 and neoplasm: In group 3 (S100A9 inhibitor Tas, n = 3), 2/3 mice had recurrent tumors, but no metastasis was observed in either the liver or lung (Fig. 7j, k), suggesting Tas might reduce tumor metastasis although showed little effect on the growth of recurrent tumors.